About
▼
Careers
Internship
MedBlog
Contact us
English (US)
▼
LOGIN
REGISTER
☰
Explore
Healthy Living
News
Health A-Z
Calculators
Articles
Drugs
Directories
Education
More
Latest Press Releases
Submit Press Releases
‹
›
Advertisement
Medindia
»
Health Press Releases A-Z
Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer
Wednesday, May 9, 2018
Cancer News
Advertisement
Latest Press Release on Cancer News
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
LONDON , April 29, 2024 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany , a leading science...
The Melanoma Research Foundation to host the DC Miles for Melanoma 5K
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, support...
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
SUZHOU, China , April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food ...
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers
The second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. The interim safety assessment was based on the review of safety data from 1...
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
SHANGHAI , April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical...
About Us
Editorial Team
Exclusive Interviews
In the News
Partners & Affiliates
Advertise With Us
Sitemap
हिन्दी
français
Español
中文
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our
Cookie Policy
,
Privacy Policy
, and our
Terms of Use
Ok, Got it.
Close
↑